These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. Brothers S; Viera A; Heimer R J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303 [TBL] [Abstract][Full Text] [Related]
3. Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic. Kleinman RA; Sanches M Drug Alcohol Depend; 2023 Jan; 242():109703. PubMed ID: 36516551 [TBL] [Abstract][Full Text] [Related]
4. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment. Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469 [No Abstract] [Full Text] [Related]
5. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation. Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394 [TBL] [Abstract][Full Text] [Related]
6. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic. Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582 [TBL] [Abstract][Full Text] [Related]
7. Trends in non-fatal and fatal opioid overdoses during the first two years of the coronavirus disease-2019 pandemic. Abasilim C; Friedman LS; Karch L; Holloway-Beth A Ann Epidemiol; 2024 Feb; 90():35-41. PubMed ID: 38501569 [TBL] [Abstract][Full Text] [Related]
8. [Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020]. Frauger E; Fouilhé N; Lacroix C; Daveluy A; Le Boisselier R; Bertin C; Revol B; Carton L; Chevalier C; Eiden C; Gibaja V; Aquizerate A; Chaouachi L; Bouquet E; Roussin A; Mallaret M; Micallef J Therapie; 2024; 79(3):297-306. PubMed ID: 37391322 [TBL] [Abstract][Full Text] [Related]
9. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions. Bouck Z; Scheim AI; Gomes T; Ling V; Caudarella A; Werb D Int J Drug Policy; 2022 Jun; 104():103680. PubMed ID: 35447476 [TBL] [Abstract][Full Text] [Related]
10. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States. Mack KA; Jones CM; Ballesteros MF Am J Transplant; 2017 Dec; 17(12):3241-3252. PubMed ID: 29145698 [TBL] [Abstract][Full Text] [Related]
11. Fatal opioid overdoses in the U.S. declined more than reported between 2017 and 2018. Boslett A; Denham A; Hill E Am J Drug Alcohol Abuse; 2021 Nov; 47(6):711-721. PubMed ID: 34107224 [No Abstract] [Full Text] [Related]
12. Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas. Rezaeiahari M; Fairman BJ Int J Drug Policy; 2022 Nov; 109():103836. PubMed ID: 36027767 [TBL] [Abstract][Full Text] [Related]
13. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone. Kelty E; Hulse G Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749 [TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic. Kennalley AL; Fanelli JL; Furst JA; Mynarski NJ; Jarvis MA; Nichols SD; McCall KL; Piper BJ BMJ Open; 2023 Nov; 13(11):e074845. PubMed ID: 37973543 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data. Korona-Bailey JA; Nechuta S; Golladay M; Moses J; Bastasch O; Krishnaswami S Ann Epidemiol; 2021 Jun; 58():149-155. PubMed ID: 33744415 [TBL] [Abstract][Full Text] [Related]
16. Overdose deaths before and during the COVID-19 pandemic in a US county. Brown CH; Johnson KA; Hills HA; Vermeer W; Clarke DL; Barnett JT; Newman RT; Burns TL; Pellan WA Front Public Health; 2024; 12():1366161. PubMed ID: 38859894 [TBL] [Abstract][Full Text] [Related]
17. Impact of a shelter-in-place order during the COVID-19 pandemic on the incidence of opioid overdoses. Rosenbaum J; Lucas N; Zandrow G; Satz WA; Isenberg D; D'Orazio J; Gentile NT; Schreyer KE Am J Emerg Med; 2021 Mar; 41():51-54. PubMed ID: 33387928 [TBL] [Abstract][Full Text] [Related]
18. Coroner county systems are associated with a higher likelihood of unclassified drug overdoses compared to medical examiner county systems. Denham A; Vasu T; Avendano P; Boslett A; Mendoza M; Hill EL Am J Drug Alcohol Abuse; 2022 Sep; 48(5):606-617. PubMed ID: 35667084 [No Abstract] [Full Text] [Related]
19. Disparities in Emergency Department Visits for Opioid and Stimulant Overdoses in Florida During COVID-19. Page TF; Chen W; Jacko JA; Sainfort F Popul Health Manag; 2022 Aug; 25(4):480-486. PubMed ID: 35238629 [TBL] [Abstract][Full Text] [Related]
20. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston. Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]